How is the Sunshine Biopharma Inc today?

The Sunshine Biopharma Inc today is trading in the down by -0.69% at 1.43.

What is Sunshine Biopharma Inc Annual Revenue?

Sunshine Biopharma Inc Annual Revenue rose 44.75%, in the last year to $34.87 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Sunshine Biopharma Inc Annual Net Profit?

Sunshine Biopharma Inc Annual Net Profit fell 13.94% in the last year to $5.13 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Sunshine Biopharma Inc Price to Earning Ratio?

Sunshine Biopharma Inc Price to Earning Ratio is -1.3, which is negative.

What is Sunshine Biopharma Inc Stock Price?

Sunshine Biopharma Inc Stock Price rose 126.98% and outperformed its sector by 71.51% in the past year.

What is Sunshine Biopharma Inc Quarterly Revenue?

Sunshine Biopharma Inc Quarterly Revenue rose 18.04% YoY to $8.9 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Sunshine Biopharma Inc Quarterly Net profit?

Sunshine Biopharma Inc Quarterly Net profit rose 8.1% YoY to $1.18 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Sunshine Biopharma Inc Debt to Equity Ratio?

Sunshine Biopharma Inc Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Sunshine Biopharma Inc Return on Equity(ROE)?

Sunshine Biopharma Inc Return on Equity(ROE) for the last financial year was -22.97%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Sunshine Biopharma Inc Mutual Fund Holding?

Sunshine Biopharma Inc Mutual Fund Holding decreased by 0% in the last quarter to 0.19.

What is Sunshine Biopharma Inc Interest Coverage Ratio?

Sunshine Biopharma Inc Interest Coverage Ratio is -610.92, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Sunshine Biopharma Inc Institutional Holding?

Sunshine Biopharma Inc Institutional Holding decreased by 0.41% in the last quarter to 0.27.

Sunshine Biopharma Inc XNAS: SBFM

Sunshine Biopharma Inc Live Share Price Today, Share Analysis and Chart

Name: Sunshine Biopharma Inc: Is Infosys Ltd. worth buying?
Item: Sunshine Biopharma Inc
Rating: 1.48675
Author: Trendlyne DVM scores

about

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs ...

1.43 -0.01 (-0.69%)

63.33% Fall from 52W High

43,861 XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Mid Valuation

32.0 / 100

Technically Bearish

27.5 / 100

140

1Yr Price target upside is 9690%

1 analysts

Sunshine Biopharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sunshine Biopharma Inc FAQ

How is Sunshine Biopharma Inc today?

Sunshine Biopharma Inc today is trading in the red, and is down by -0.69% at 1.43.

How has Sunshine Biopharma Inc performed historically?

Sunshine Biopharma Inc is currently trading down -0.69% on an intraday basis. In the past week the stock fell -0.69%. stock has been down -37.55% in the past quarter and rose 126.98% in the past year. You can view this in the overview section.